Editorial: estimating the costs of care in irritable bowel syndrome—a necessary step to enhance value‐based care for a high‐prevalence, low‐cost condition
LINKED CONTENT This article is linked to Goodoory et al papers. To view these articles, visit https://doi.org/10.1111/apt.16939 and https://doi.org/10.1111/apt.16966
Gespeichert in:
Veröffentlicht in: | Alimentary pharmacology & therapeutics 2022-06, Vol.55 (12), p.1588-1589 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1589 |
---|---|
container_issue | 12 |
container_start_page | 1588 |
container_title | Alimentary pharmacology & therapeutics |
container_volume | 55 |
creator | Berinstein, Jeffrey A. Fendrick, A. Mark |
description | LINKED CONTENT
This article is linked to Goodoory et al papers. To view these articles, visit https://doi.org/10.1111/apt.16939 and https://doi.org/10.1111/apt.16966 |
doi_str_mv | 10.1111/apt.16956 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2669503916</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2668604736</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3186-d489aa8e896cdbc0d58f388548bcbb76a2bc2001d2118f6f3b2c842163620d6e3</originalsourceid><addsrcrecordid>eNp1kU1uFDEQhS1ERIaBBRdAltiAlE78M-1xs4uiECJFgkVYt_xTnXHksRvbzWh2HIEFJ-BonAQPHVggUZuSSl-9Kr2H0AtKTmmtMzWWUyq6VjxCC8pF2zDCxWO0IEx0DZOUH6OnOd8TQsSasCfomLeCko6vF-jHpXUlJqf8Wwy5uK0qLtzhsgFsYi4ZxwEblQC7gF1KrijtAeu4A4_zPtgUt_Dz63eFAxjIWaU9zgVGXCKGsFHBAP6i_FSZb1plsLPYEBNWeOPuNnU-JqgIVPQE-7irk8Plej7U11wMz9DRoHyG5w99iT69u7y9eN_cfLi6vji_aQynUjR2JTulJMhOGKsNsa0cuJTtSmqj9Voopg0jhFpGqRzEwDUzcsWo4IIRK4Av0etZd0zx81TN6LcuG_BeBYhT7pmoFhPe1Y0levUPeh-nFOp3B0oKslrzA_VmpkyKOScY-jFVg9O-p6Q_BNfX4PrfwVX25YPipLdg_5J_kqrA2QzsnIf9_5X684-3s-QvApaoNA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2668604736</pqid></control><display><type>article</type><title>Editorial: estimating the costs of care in irritable bowel syndrome—a necessary step to enhance value‐based care for a high‐prevalence, low‐cost condition</title><source>Wiley Online Library Journals Frontfile Complete</source><source>Wiley Online Library Free Content</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Berinstein, Jeffrey A. ; Fendrick, A. Mark</creator><creatorcontrib>Berinstein, Jeffrey A. ; Fendrick, A. Mark</creatorcontrib><description>LINKED CONTENT
This article is linked to Goodoory et al papers. To view these articles, visit https://doi.org/10.1111/apt.16939 and https://doi.org/10.1111/apt.16966</description><identifier>ISSN: 0269-2813</identifier><identifier>EISSN: 1365-2036</identifier><identifier>DOI: 10.1111/apt.16956</identifier><identifier>PMID: 35610937</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Irritable bowel syndrome</subject><ispartof>Alimentary pharmacology & therapeutics, 2022-06, Vol.55 (12), p.1588-1589</ispartof><rights>2022 John Wiley & Sons Ltd.</rights><rights>Copyright © 2022 John Wiley & Sons Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3186-d489aa8e896cdbc0d58f388548bcbb76a2bc2001d2118f6f3b2c842163620d6e3</citedby><cites>FETCH-LOGICAL-c3186-d489aa8e896cdbc0d58f388548bcbb76a2bc2001d2118f6f3b2c842163620d6e3</cites><orcidid>0000-0002-7734-6742 ; 0000-0001-7631-9665</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fapt.16956$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fapt.16956$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,1427,27901,27902,45550,45551,46384,46808</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35610937$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Berinstein, Jeffrey A.</creatorcontrib><creatorcontrib>Fendrick, A. Mark</creatorcontrib><title>Editorial: estimating the costs of care in irritable bowel syndrome—a necessary step to enhance value‐based care for a high‐prevalence, low‐cost condition</title><title>Alimentary pharmacology & therapeutics</title><addtitle>Aliment Pharmacol Ther</addtitle><description>LINKED CONTENT
This article is linked to Goodoory et al papers. To view these articles, visit https://doi.org/10.1111/apt.16939 and https://doi.org/10.1111/apt.16966</description><subject>Irritable bowel syndrome</subject><issn>0269-2813</issn><issn>1365-2036</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp1kU1uFDEQhS1ERIaBBRdAltiAlE78M-1xs4uiECJFgkVYt_xTnXHksRvbzWh2HIEFJ-BonAQPHVggUZuSSl-9Kr2H0AtKTmmtMzWWUyq6VjxCC8pF2zDCxWO0IEx0DZOUH6OnOd8TQsSasCfomLeCko6vF-jHpXUlJqf8Wwy5uK0qLtzhsgFsYi4ZxwEblQC7gF1KrijtAeu4A4_zPtgUt_Dz63eFAxjIWaU9zgVGXCKGsFHBAP6i_FSZb1plsLPYEBNWeOPuNnU-JqgIVPQE-7irk8Plej7U11wMz9DRoHyG5w99iT69u7y9eN_cfLi6vji_aQynUjR2JTulJMhOGKsNsa0cuJTtSmqj9Voopg0jhFpGqRzEwDUzcsWo4IIRK4Av0etZd0zx81TN6LcuG_BeBYhT7pmoFhPe1Y0levUPeh-nFOp3B0oKslrzA_VmpkyKOScY-jFVg9O-p6Q_BNfX4PrfwVX25YPipLdg_5J_kqrA2QzsnIf9_5X684-3s-QvApaoNA</recordid><startdate>202206</startdate><enddate>202206</enddate><creator>Berinstein, Jeffrey A.</creator><creator>Fendrick, A. Mark</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope><scope>M7N</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7734-6742</orcidid><orcidid>https://orcid.org/0000-0001-7631-9665</orcidid></search><sort><creationdate>202206</creationdate><title>Editorial: estimating the costs of care in irritable bowel syndrome—a necessary step to enhance value‐based care for a high‐prevalence, low‐cost condition</title><author>Berinstein, Jeffrey A. ; Fendrick, A. Mark</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3186-d489aa8e896cdbc0d58f388548bcbb76a2bc2001d2118f6f3b2c842163620d6e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Irritable bowel syndrome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Berinstein, Jeffrey A.</creatorcontrib><creatorcontrib>Fendrick, A. Mark</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Alimentary pharmacology & therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Berinstein, Jeffrey A.</au><au>Fendrick, A. Mark</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Editorial: estimating the costs of care in irritable bowel syndrome—a necessary step to enhance value‐based care for a high‐prevalence, low‐cost condition</atitle><jtitle>Alimentary pharmacology & therapeutics</jtitle><addtitle>Aliment Pharmacol Ther</addtitle><date>2022-06</date><risdate>2022</risdate><volume>55</volume><issue>12</issue><spage>1588</spage><epage>1589</epage><pages>1588-1589</pages><issn>0269-2813</issn><eissn>1365-2036</eissn><abstract>LINKED CONTENT
This article is linked to Goodoory et al papers. To view these articles, visit https://doi.org/10.1111/apt.16939 and https://doi.org/10.1111/apt.16966</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>35610937</pmid><doi>10.1111/apt.16956</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-7734-6742</orcidid><orcidid>https://orcid.org/0000-0001-7631-9665</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0269-2813 |
ispartof | Alimentary pharmacology & therapeutics, 2022-06, Vol.55 (12), p.1588-1589 |
issn | 0269-2813 1365-2036 |
language | eng |
recordid | cdi_proquest_miscellaneous_2669503916 |
source | Wiley Online Library Journals Frontfile Complete; Wiley Online Library Free Content; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Irritable bowel syndrome |
title | Editorial: estimating the costs of care in irritable bowel syndrome—a necessary step to enhance value‐based care for a high‐prevalence, low‐cost condition |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T04%3A27%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Editorial:%20estimating%20the%20costs%20of%20care%20in%20irritable%20bowel%20syndrome%E2%80%94a%20necessary%20step%20to%20enhance%20value%E2%80%90based%20care%20for%20a%20high%E2%80%90prevalence,%20low%E2%80%90cost%20condition&rft.jtitle=Alimentary%20pharmacology%20&%20therapeutics&rft.au=Berinstein,%20Jeffrey%20A.&rft.date=2022-06&rft.volume=55&rft.issue=12&rft.spage=1588&rft.epage=1589&rft.pages=1588-1589&rft.issn=0269-2813&rft.eissn=1365-2036&rft_id=info:doi/10.1111/apt.16956&rft_dat=%3Cproquest_cross%3E2668604736%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2668604736&rft_id=info:pmid/35610937&rfr_iscdi=true |